Search Results

Found 5,227 results

Event
October 25, 2023

Preparing for the Federal Legalization of Cannabis

Over the past decade, a wave of state legalization of cannabis has spread across the US. Currently, 37 states permit…
pharmaceuticals
Event
September 14, 2023

The Continued Conundrum of Drug Pricing

Over the past century, pharmaceutical product innovation has changed the course of human disease. The growth of small molecule products…
Op-Ed
August 25, 2023

Too Fast or Too Slow: Ambivalence about Drug Development Affects Health

Investments in clinical development programs, including those for new treatments for existing conditions, are influenced by the policy, business, and…
Multimedia
August 23, 2023

How AI Could Save Healthcare

Dr. Brian Miller joined Rep. Crenshaw to talk about the coming Artificial Intelligence (AI) revolution in healthcare. They cover the…
By Brian J. Miller | Dan Crenshaw
Joe Biden makes remarks on the DISCLOSE Act
Post
August 23, 2023

Senator Biden Voted for Reagan’s 1981 Spending and Tax Cuts

As President Biden gears up for his re-election effort, his team is emphasizing his strong opposition to changing Social Security…
Medicare enrollment form
Op-Ed
August 16, 2023

The 5 Biggest Mistakes People Make When Picking a Medicare Plan

If you’re thinking about retiring, or are already covered by Medicare, you might be overwhelmed by all the choices out…
Press
August 09, 2023

Discussing Appropriate Use of Diabetes Drugs: Gottlieb on CNBC’s “Squawk Box”

Senior Fellow Scott Gottlieb discusses the growing interest in new diabetes drugs on CNBC’s Squawk Box.
Post
August 08, 2023

Making a Deposit into a Congressional Bank Account

The Senate Finance Committee’s recently-approved Modernizing and Ensuring PBM Accountability Act includes a provision directing resources to a mysterious and…
Report
August 08, 2023

Rationing Medicine Through Bureaucracy: Authorization Restrictions in Medicare

ABSTRACT We study the trade-off between bureaucratic costs and reductions in moral hazard induced by managedcare tools in healthcare. We…
Op-Ed
August 04, 2023

‘The Good Virus’ Review: An Unlikely Healer

In 2015, Tom Patterson, a psychiatry professor at the University of California, San Diego, fell ill while on holiday, soon…
Post
August 04, 2023

Prior Authorization Reduces Net Costs of Medicare Part D

Our evidence clearly shows that prior authorization has an important effect on drug spending—a fact that should be central to…
Article
August 01, 2023

Lessons for Biopharma from a Healthcare AI Pioneer

As drug developers consider how to leverage AI and other emerging digital and data technologies, they look to related businesses,…
Press
July 31, 2023

Discussing the Opportunities Related to AI in Health Care: Gottlieb on CNBC’s “Squawk Box”

Senior Fellow Scott Gottlieb discusses the opportunities related to AI in health care on CNBC’s Squawk Box.
Testimony
July 27, 2023

The Costs of Diabetes and Considerations for Policy Responses

In his testimony, Ippolito explains what we know about the costs of diabetes and, in turn, potential value stemming from…
Press
July 19, 2023

Discussing the Danger of Lead Cables Laid by Telecom Companies: Gottlieb on CNBC’s “Power Lunch”

Senior Fellow Scott Gottlieb discusses the danger related to lead cable laid by Telecom companies on CNBC’s Power Lunch.
Testimony
July 19, 2023

Burdensome Red Tape: Overregulation in Health Care and the Impact on Small Businesses

In his testimony before the House Small Business Committee, Brian Miller discusses the increasing regulatory burden placed on health care…
Testimony
July 18, 2023

Innovation Saves Lives: Evaluating Medicare Coverage Pathways for Innovative Drugs, Medical Devices, and Technology

As one of the most entrepreneurial countries in the world, we have made a choice to invest in the development…
Post
July 17, 2023

Biden’s Underwhelming Plan to Cut Health Costs

President Biden’s latest plan to lower health care costs for American households, which he outlined recently in remarks at the…
Op-Ed
July 12, 2023

Ten Health Care Ideas for No One in Particular

The unifying theme for a competition-focused health care plan should be providing more structure to the market so consumers can…
Press
July 07, 2023

Discussing the FDA’s New Alzheimer’s Drug Approval: Gottlieb on CNBC’s “Squawk Box”

Senior Fellow Scott Gottlieb discusses the Food and Drug Administration’s new Alzheimer’s drug approval on CNBC’s Squawk Box.